WADA is pleased to provide to stakeholders Medical Information to Support the Decisions of Therapeutic Use Exemptions Committees (TUEC), now available in English. This document was drafted in order to guide and assist TUECs in decision making for TUE applications. It was finalized based on the consensus reached in the plenary session of the Workshop on Medical Aspects of TUEs co-organized by WADA and the German National Anti-Doping Agency (NADA) in Bonn, on 13 December 2006. The document on asthma will be available in the coming weeks.
As with all Guidelines under the World Anti-Doping Program, these documents are subject to ongoing review and reassessment. WADA encourages feedback on the content of the Guidelines and recommends that stakeholders continue to consult the WADA Web site for the latest version.
Click here for more information.